Abstract
Schizophrenia, and other primary psychotic disorders, are complex and heterogeneous in symptom presentation. Until fairly recently, primary psychotic disorders have been thought of as primarily “organic” and responsive only to medication. Cognitive behavioral therapy (CBT) represents a promising adjunctive approach to pharmacotherapy for treatment refractory psychosis. CBT is based on a cognitive behavioral formulation of psychosis and associated distress and functional impairment and is provided in the context of a strong therapeutic alliance. This chapter reviews clinical tips for forming a collaborative stance with patients suffering from psychosis as well as CBT techniques for targeting hallucinations and delusions. A case illustration is provided.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Zubin J, Spring B. Vulnerability – a new view of schizophrenia. J Abnorm Psychol. 1977;86(2):103–26.
Nuechterlein KH, Dawson ME, Gitlin M, Ventura J, Goldstein MJ, Snyder KS, et al. Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophr Bull. 1992;18(3):387–425.
Cardno AG, Gottesman II. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet. 2000;97(1):12–7.
Tsuang MT, Stone WS, Faraone SV. Genes, environment and schizophrenia. Br J Psychiatry Suppl. 2001;40:S18–24.
Brown AS, Schaefer CA, Wyatt RJ, Goetz R, Begg MD, Gorman JM, et al. Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study. Schizophr Bull. 2000;26(2):287–95.
Malaspina D, Harlap S, Fennig S, Heiman D, Nahon D, Feldman D, et al. Advancing paternal age and the risk of schizophrenia. Arch Gen Psychiatry. 2001;58(4):361–7.
Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet. 1987;2(8574):1483–6.
McDonald C, Murray RM. Early and late environmental risk factors for schizophrenia. Brain Res Brain Res Rev. 2000;31(2–3):130–7.
van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med. 2009;39(2):179–95.
Jones SR, Fernyhough C. A new look at the neural diathesis–stress model of schizophrenia: the primacy of social-evaluative and uncontrollable situations. Schizophr Bull. 2007;33(5):1171–7.
Manchanda R, Norman RM, Malla AK, Harricharan R, Northcott S. Persistent psychoses in first episode patients. Schizophr Res. 2005;80(1):113–6.
Chambers JS, Perrone-Bizzozero NI. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder. Neurochem Res. 2004;29(12):2293–302.
Mueser KT, Bellack AS, Morrison RL, Wade JH. Gender, social competence, and symptomatology in schizophrenia: a longitudinal analysis. J Abnorm Psychol. 1990;99(2):138–47.
Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008;65(1):28–37.
Ruhrmann S, Schultze-Lutter F, Salokangas RK, Heinimaa M, Linszen D, Dingemans P, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry. 2010;67(3):241–51.
Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ, et al. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry. 2005;162(1):71–8.
Hafner H, Maurer K, van der Heiden W. ABC schizophrenia study: an overview of results since 1996. Soc Psychiatry Psychiatr Epidemiol. 2013;48(7):1021–31.
Phillips LK, Seidman LJ. Emotion processing in persons at risk for schizophrenia. Schizophr Bull. 2008;34(5):888–903.
Brewer WJ, Wood SJ, Phillips LJ, Francey SM, Pantelis C, Yung AR, et al. Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull. 2006;32(3):538–55.
Norman RM, Lewis SW, Marshall M. Duration of untreated psychosis and its relationship to clinical outcome. Br J Psychiatry Suppl. 2005;48:S19–23.
McGorry PD, Killackey E, Yung A. Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry. 2008;7(3):148–56.
Emsley R, Rabinowitz J, Medori R. Early Psychosis Global Working Group. Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates. Schizophr Res. 2007;89(1–3):129–39.
Emsley R, Oosthuizen PP, Kidd M, Koen L, Niehaus DJ, Turner HJ. Remission in first-episode psychosis: predictor variables and symptom improvement patterns. J Clin Psychiatry. 2006;67(11):1707–12.
Cavelti M, Beck EM, Kvrgic S, Kossowsky J, Vauth R. The role of subjective illness beliefs and attitude toward recovery within the relationship of insight and depressive symptoms among people with schizophrenia spectrum disorders. J Clin Psychol. 2012;68(4):462–76.
Zisook S, Montross L, Kasckow J, Mohamed S, Palmer BW, Patterson TL, et al. Subsyndromal depressive symptoms in middle-aged and older persons with schizophrenia. Am J Geriatr Psychiatry. 2007;15(12):1005–14.
Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res. 1999;35(Suppl):S93–100.
Farris C, Brems C, Johnson ME, Wells R, Burns R, Kletti N. A comparison of schizophrenic patients with or without coexisting substance use disorder. Psychiatry Q. 2003;74(3):205–22.
Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry. 2005;62(3):247–53.
Pantelis C, Barnes TR. Drug strategies and treatment-resistant schizophrenia. Aust N Z J Psychiatry. 1996;30(1):20–37.
Garety PA, Fowler D, Kuipers E. Cognitive-behavioral therapy for medication-resistant symptoms. Schizophr Bull. 2000;26(1):73–86.
Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull. 2008;34(3):523–37.
Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB. Schizophrenia Patient Outcomes Research Team. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophr Bull. 2010;36(1):94–103.
Maher BA. Delusional thinking and perceptual disorder. J Individ Psychol. 1974;30(1):98–113.
Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160(1):13–23.
Bentall RP. The illusion of reality: a review and integration of psychological research on hallucinations. Psychol Bull. 1990;107(1):82–95.
Frank JD, Dietz PE. Psychotherapy and the human predicament: a psychosocial approach, vol. 20. New York, NY: Schocken Books; 1978. p. 330.
Nelson HE, Nelson HE. Cognitive-behavioural therapy with delusions and hallucinations: a practice manual. 2nd ed. Cheltenham: Nelson Thornes; 2005. p. 339.
Kingdon DG, Turkington D. Cognitive therapy of schizophrenia. New York, NY: Guilford; 2008. p. 219.
Fowler DR, Garety PA, Kuipers L. Cognitive behaviour therapy for psychosis: theory and practice. Chichester: Wiley; 1995. p. 194.
Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry Suppl. 1989;7:59–67.
Ventura J, Nuechterlein KH, Subotnik KL, Gutkind D, Gilbert EA. Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Res. 2000;97(2–3):129–35.
Andreasen NC. Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry. 1982;39(7):784–8.
Andreasen NC. Scale for the assessment of positive symptoms. Iowa City: University of Iowa; 1984.
Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999;29(4):879–89.
Chadwick P. The revised beliefs about voices questionnaire (BAVQ-R). Br J Psychiatry. 2000;177(3):229–32.
Fenigstein A, Vanable PA. Paranoia and self-consciousness. J Pers Soc Psychol. 1992;62(1):129–38.
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–7.
Beck AT, Steer RA, Ball R, Ranieri W. Comparison of beck depression inventories-IA and -II in psychiatric outpatients. J Pers Assess. 1996;67(3):588–97.
Fowler D, Hodgekins J, Painter M, Reilly T, Crane C, Macmillan I, et al. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform Study (improving social recovery in early psychosis). Psychol Med. 2009;39(10):1627–36.
Cather C, Penn D, Otto MW, Yovel I, Mueser KT, Goff DC. A pilot study of functional cognitive behavioral therapy (fCBT) for schizophrenia. Schizophr Res. 2005;74(2–3):201–9.
Grant PM, Huh GA, Perivoliotis D, Stolar NM, Beck AT. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Arch Gen Psychiatry. 2012;69(2):121–7.
Nuechterlein KH, Dawson ME. A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull. 1984;10(2):300–12.
Johns LC, van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev. 2001;21(8):1125–41.
Tarrier N, Harwood S, Yusopoff L, Beckett R, Baker A. Coping strategy enhancement (CSE): A method of treating residual schizophrenic symptoms. Behav Cogn Psychother. 1990;18(04):283–93.
Hatashita-Wong M, Silverstein SM. Coping with voices: selective attention training for persistent auditory hallucinations in treatment refractory schizophrenia. Psychiatry. 2003;66(3):255–61.
Valmaggia LR, Bouman TK, Schuurman L. Attention training with auditory hallucinations: a case study. Cogn Behav Pract. 2007;14(2):127–33.
Miller WR, Rollnick S. Motivational interviewing: preparing people for change. 2nd ed. New York, NY: Guilford; 2002. p. 428.
Mueser KT, Rosenberg SD, Xie H, Jankowski MK, Bolton EE, Lu W, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008;76(2):259–71.
McQuaid JR, Granholm E, McClure FS, Roepke S, Pedrelli P, Patterson TL, et al. Development of an integrated cognitive-behavioral and social skills training intervention for older patients with schizophrenia. J Psychother Pract Res. 2000;9(3):149–56.
Garety PA, Freeman D. Cognitive approaches to delusions: a critical review of theories and evidence. Br J Clin Psychol. 1999;38(Pt 2):113–54.
Rector NA, Beck AT, Stolar N. The negative symptoms of schizophrenia: a cognitive perspective. Can J Psychiatry. 2005;50(5):247–57.
Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive symptoms of psychosis. Psychol Med. 2001;31(2):189–95.
Freeman D, Garety PA, Bebbington P, Slater M, Kuipers E, Fowler D, et al. The psychology of persecutory ideation II: a virtual reality experimental study. J Nerv Ment Dis. 2005;193(5):309–15.
Beck JS, Beck JS. Cognitive behavior therapy: basics and beyond. 2nd ed. New York, NY: Guilford; 2011. p. 391.
Gottlieb JD, Cather C, Shanahan M, Creedon T, Macklin EA, Goff DC. D-Cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia. Schizophr Res. 2011;131(1–3):69–74.
CBT for Psychosis: Additional Resources—For Practitioners
Beck TA, Rector NA, Stolar N, Grant P. Schizophrenia: cognitive theory, research, and therapy. New York, NY: Guilford Press; 2009.
Chadwick P, Birchwood M, et al. Cognitive therapy of delusions, voices and paranoia. Chichester: John Wiley and Sons; 1996.
Fowler D, Garety P, et al. Cognitive behaviour therapy for psychosis theory and practice. Chichester: John Wiley & Sons; 1995.
Hagen R, Turkington D, Berge T, Gråwe RW, editors. CBT for psychosis: a symptom-based approach. New York, NY: Routledge; 2013.
Kingdon D, Turkington D. Cognitive therapy of schizophrenia. New York, NY: Guilford; 2005.
Morrison AP, Renton JC, Dunn H, Williams S, Bentall RP. Cognitive therapy for psychosis: a formulation based approach. Hove: Brunner-Routledge; 2004.
Nelson HE. Cognitive behavioural therapy with schizophrenia. a practice manual. Cheltenham: Stanley Thornes Publishers Ltd.; 1997.
Van der Gaag M, Nieman D, van den Berg D. CBT for those at risk of a first episode of psychosis. New York, NY: Routledge; 2013.
Wright JH, Turkington D, Kingdon DG, Ramirez Basco M. Cognitive-behavior therapy for severe mental illness: an illustrated guide. Washington DC: American Psychiatric Press; 2009.
CBT for Psychosis: Additional Resources—For Clients
Freeman D, Freeman J, Garety P. Overcoming paranoia and suspicious thoughts. London: Robinson; 2006.
CBT for Psychosis: Additional Resources—For Families
Amadour X. I am not sick and I don’t need help! How to help someone with mental illness accept treatment. New York, NY: Vida Press, LLC.; 2010.
Mueser KT, Gingerich S. The complete family guide to schizophrenia: helping your loved one get the most out of life. New York, NY: Guilford; 2006.
CBT for Psychosis: Additional Resources—Websites
www.nami.org (see information on Family to Family program)
http://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Marcus, P.H., Cather, C. (2016). Cognitive Behavioral Approaches for Schizophrenia and Other Psychotic Disorders. In: Petersen, T., E. Sprich, S., Wilhelm, S. (eds) The Massachusetts General Hospital Handbook of Cognitive Behavioral Therapy. Current Clinical Psychiatry. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2605-3_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2605-3_14
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2604-6
Online ISBN: 978-1-4939-2605-3
eBook Packages: MedicineMedicine (R0)